arrow
A

Anand K. Ganesan

university of california
H指数:28
被引数:2,190

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vitiligo Biomarker CXCL10 Correlates With Clinical Response to Ruxolitinib Cream in the Phase 2 Randomized TRuE-V Mechanism-of-Action Study

白癜风生物标志物CXCL10与Ruxolitinib乳膏在TRuE-V机制研究2期随机试验中的临床反应相关

2026-10-130
OAAI
Assessment of vitiligo in clinical practice: a cross-sectional survey among experts

白癜风临床评估:一项针对专家的横断面调查

2025-10-100
OA
Autologous cell harvesting device provides repigmentation and improves quality-of-life for patients with stable vitiligo lesions in a large and diverse patient population

自体细胞采集装置为患有稳定型白癜风病灶的大规模且多样化的患者群体提供了重新着色,并改善了其生活质量。

2025-03-280
OA
Effective and durable repigmentation for stable vitiligo: A randomized within- subject controlled trial assessing treatment with autologous skin cell suspension transplantation
2024-12-010
OAAI
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial

口服利来替尼治疗活动性非节段性白癜风的疗效和安全性: 一项随机2b期临床试验

2023-02-0156
PRE
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer
2022-04-0113
OAAI
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer (vol 39, 110641, 2022)
2022-04-011
OA